66 related articles for article (PubMed ID: 6138953)
1. Brain iron and dopamine receptor function.
Youdim MB; Ben-Shachar D; Ashkenazi R; Yehuda S
Adv Biochem Psychopharmacol; 1983; 37():309-21. PubMed ID: 6138953
[TBL] [Abstract][Full Text] [Related]
2. Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates.
Youdim MB; Ashkenazi R; Ben-Shachar D; Yehuda S
Adv Neurol; 1984; 40():159-70. PubMed ID: 6695592
[TBL] [Abstract][Full Text] [Related]
3. Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission.
Youdim MB; Ben-Shachar D
Isr J Med Sci; 1987; 23(1-2):19-25. PubMed ID: 3032848
[TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
Lerer B
Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
[TBL] [Abstract][Full Text] [Related]
6. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.
Zhao H; Zhu W; Pan T; Xie W; Zhang A; Ondo WG; Le W
J Neurosci Res; 2007 Apr; 85(5):1065-76. PubMed ID: 17342757
[TBL] [Abstract][Full Text] [Related]
8. Nutritional iron and dopamine binding sites in the rat brain.
Ashkenazi R; Ben-Shachar D; Youdim MB
Pharmacol Biochem Behav; 1982; 17 Suppl 1():43-7. PubMed ID: 7184034
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
Ben-Shachar D; Youdim MB
J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
[TBL] [Abstract][Full Text] [Related]
10. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
11. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of fluperlapine compared with clozapine.
Eichenberger E
Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
[TBL] [Abstract][Full Text] [Related]
13. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL
J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828
[TBL] [Abstract][Full Text] [Related]
14. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
15. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
16. Enhanced dopamine D2 receptor function in hypothalamus and corpus striatum: their role in liver, plasma and in vitro hepatocyte ALDH regulation in ethanol treated rats.
Akash KG; Anju TR; Peeyush KT; Paulose CS
J Biomed Sci; 2008 Sep; 15(5):623-31. PubMed ID: 18536982
[TBL] [Abstract][Full Text] [Related]
17. Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.
Kumar V; Khanna VK; Seth PK; Singh PN; Bhattacharya SK
Phytother Res; 2002 May; 16(3):210-6. PubMed ID: 12164263
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
19. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
[TBL] [Abstract][Full Text] [Related]
20. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
